Cocaine Use Disorders
9
0
0
8
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
0.0%
0 terminated out of 9 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
63%
5 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (9)
Glutamatergic Modulation of Motivation Enhancement: A Pilot Feasibility Trial
Project IMPACT: Improving Memory Performance by Applying Cognitive Training
D-Cycloserine and Cue Exposure in Cocaine-Dependent Individuals
A Novel Anti-Obesity Drug Combination as a Pharmacotherapy for Cocaine Dependence
A Transtheoretical Model Group Therapy for Cocaine
D-Cycloserine Facilitation of Cocaine - Cue Extinction
Lorcaserin Intra Venous Cocaine Effects
Impact of Buspirone Maintenance on the Reinforcing Effects of Cocaine
Combined Donepezil and Selegiline Effects on Cocaine-Reinforced Behavior